ActiveCare® in CCJR 2014: Just Say No to Drugs”
ActiveCare® participated in CCJR 2014, Current Concepts in Joint Replacement, held in Florida, Dec 10-14.
During this conference, leading orthopedic surgeon Robert L. Barrack, M.D., Chief of Orthopedics at Barnes Jewish Hospital and professor at Washington University School of Medicine in St. Louis, MO, gave a talk named ““JUST SAY NO TO DRUGS”.
Dr. Barrack provided updated results on studies that show effectiveness of ActiveCare® compared to anticoagulant drugs, with fewer complications in terms bleeding, drainage and readmissions.
“We should be using a stronger anticoagulant selectively rather than routinely…” said Dr. Barrack during an interview at CCJR 2014
During the latest CCJR 2014, Current Concepts in Joint Replacement, leading orthopedic surgeon Dr. Barrack, Chief of Orthopedics at Barnes Jewish Hospital and professor at Washington University School of Medicine was interviewed by Orthopedics Today on the results of the large scale studies he participated in.
Referring to ActiveCare® studies, here are his conclusions:
“We should be using a stronger anticoagulant selectively rather than routinely, because unless a patient has above average risk of having a blood clot we’re probably exposing him to unnecessary degree of risk of complications than ended for the typical patient that is having a total joint. Using a mobile compression device is an equal level of safety for preventing thromboembolism to anticoagulants without the risk of anticoagulants”.